News
Considerations of Sex and Gender in FDA Tobacco Regulation
Danielle R. Davis, PhD, assistant professor of psychiatry; Suchitra Krishnan-Sarin, PhD, Albert E. Kent Professor of Psychiatry; and Carolyn M. Mazure, PhD, Norma Weinberg Spungen and Joan Lebson Bildner Professor in Women's Health Research and Professor of Psychiatry and of Psychology, and director, Women's Health Research at Yale, provide examples of proposed regulatory changes by the FDA that could benefit from a greater focus on women and the influence of sex and gender on tobacco use.
Source: JAMA